Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.51 CAD | 0.00% | -6.79% | -15.64% |
05-15 | Transcript : Oncolytics Biotech Inc. - Shareholder/Analyst Call | |
05-15 | Oncolytics Biotech Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Pancreatic Cancer Trial | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.64% | 84.16M | |
+44.48% | 54.04B | |
+43.57% | 41.96B | |
-0.86% | 41.92B | |
-7.59% | 28.35B | |
+12.30% | 26.35B | |
-21.83% | 19B | |
+7.15% | 13B | |
+29.40% | 12.28B | |
+25.15% | 12.19B |
- Stock Market
- Equities
- ONC Stock
- News Oncolytics Biotech Inc.
- Transcript : Oncolytics Biotech Inc., Q3 2023 Earnings Call, Nov 03, 2023